| Literature DB >> 30247717 |
Cristina Cosentino1, Sanna Toivonen1, Esteban Diaz Villamil1, Mohamed Atta2, Jean-Luc Ravanat3, Stéphane Demine1, Andrea Alex Schiavo1, Nathalie Pachera1, Jean-Philippe Deglasse4, Jean-Christophe Jonas4, Diego Balboa5, Timo Otonkoski5,6, Ewan R Pearson7, Piero Marchetti8, Décio L Eizirik1, Miriam Cnop1,9, Mariana Igoillo-Esteve1.
Abstract
Transfer RNAs (tRNAs) are non-coding RNA molecules essential for protein synthesis. Post-transcriptionally they are heavily modified to improve their function, folding and stability. Intronic polymorphisms in CDKAL1, a tRNA methylthiotransferase, are associated with increased type 2 diabetes risk. Loss-of-function mutations in TRMT10A, a tRNA methyltransferase, are a monogenic cause of early onset diabetes and microcephaly. Here we confirm the role of TRMT10A as a guanosine 9 tRNA methyltransferase, and identify tRNAGln and tRNAiMeth as two of its targets. Using RNA interference and induced pluripotent stem cell-derived pancreatic β-like cells from healthy controls and TRMT10A-deficient patients we demonstrate that TRMT10A deficiency induces oxidative stress and triggers the intrinsic pathway of apoptosis in β-cells. We show that tRNA guanosine 9 hypomethylation leads to tRNAGln fragmentation and that 5'-tRNAGln fragments mediate TRMT10A deficiency-induced β-cell death. This study unmasks tRNA hypomethylation and fragmentation as a hitherto unknown mechanism of pancreatic β-cell demise relevant to monogenic and polygenic forms of diabetes.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30247717 PMCID: PMC6212784 DOI: 10.1093/nar/gky839
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971